Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
Holding KIDS?
Track your performance easily
KIDS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$23.10 - $38.99
Previous Close$31.44
Volume162.78K
Average Volume (3M)165.80K
Market Cap
$761.30M
Enterprise Value$732.53M
Total Cash (Recent Filing)$28.93M
Total Debt (Recent Filing)$156.00K
Price to Earnings (P/E)―
Beta1.49
Next Earnings
Nov 06, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding24,214,426
10 Day Avg. Volume199,160
30 Day Avg. Volume165,798
Standard Deviation0.12
R-Squared0.27
Alpha-0.00913
Financial Highlights & Ratios
Price to Book (P/B)3.92
Price to Sales (P/S)3.94
Price to Cash Flow (P/CF)-31.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.18
Enterprise Value/Gross Profit6.58
Enterprise Value/Ebitda-62.12
Forecast
1Y Price Target
$50.00Price Target Upside66.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
OrthoPediatrics News
PremiumCompany Announcements
OrthoPediatrics Enhances Investor Relations with Strategic Presentations
PremiumCompany Announcements
OrthoPediatrics Enhances Financial Flexibility and Shareholder Value
PremiumPress Releases
OrthoPediatrics Corp. Announces Private FinancingBulls Say, Bears Say
Bulls Say
Acquisition ImpactThe recent acquisition of Boston O&P is expected to significantly accelerate the company's growth rate and provide a sustained positive impact.
Market PositionOrthoPediatrics' strategy to broaden its model across high-volume children's hospitals in the U.S. positions it as a leading growth small cap company in MedTech.
Revenue GrowthKIDS reiterated its full-year 2024 revenue guidance, representing 32%-34% growth year-over-year, which includes contributions from its recent acquisition of Boston O&P.
Bears Say
ExpensesOperating expenses and Selling and Marketing expenses have significantly increased.
ProfitabilityGross margin decreased from 74.6% to 72.0%.
Revenue GrowthCOVID-19 and its lingering headwinds and RSV both negatively impacted the business, causing core revenue growth to lag.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $23.10 and its highest was $38.99 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
Currently, no data Available
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Nov 06, 2024 which is in 74 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Aug 05, 2024. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.263 by $0.033.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -$0.23.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 24,214,426 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.263. Following the earnings report the stock price went down -6.129%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Among the largest hedge funds holding OrthoPediatrics Corp’s share is Royce & Associates LLC. It holds OrthoPediatrics Corp’s shares valued at 380K.
---
OrthoPediatrics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$50.00 (66.17% Upside)
$50.00 (66.17% Upside)
Hedge Fund Trend
Decreased
By 50.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $293.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.69%
12-Months-Change
Fundamentals
Return on Equity
-6.68%
Trailing 12-Months
Asset Growth
-0.94%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.
---
KIDS Earnings Call
Q2 2024
0:00 / 0:00
---
KIDS Stock 12 Month Forecast
Average Price Target
$50.00
▲(66.17% Upside)
Technical Analysis
Best Analysts Covering KIDS
1 Year
1 Year Success Rate
13/30 ratings generated profit
1 Year Average Return
-6.97%
reiterated a buy rating 6 months ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 43.33% of your transactions generating a profit, with an average return of -6.97% per trade.
---